Know Cancer

Target Cancer

Fight Cancer

Know Cancer

Breakthrough genomic cancer testing from a single blood draw

Guardant Health has helped thousands of oncologists learn accurate and actionable information about tens of thousands of patients, while avoiding the costs and risks of tissue biopsies. Our genomic test helps match advanced-cancer patients to approved targeted therapies as well as drugs in clinical trials.

What is Guardant360?

Non-invasive

A simple blood draw is all it takes

Comprehensive

Our 73-gene panel targets actionable somatic alterations

Proven

Used by all 27 National Comprehensive Cancer Network Centers

Tumors evolve
Treatment must too

Access precision care through a simple blood test

The precise genomic picture without the risks

See how non-invasive, comprehensive
tumor-DNA testing helped Susan and Carole

Trusted by leading oncologists at top cancer centers

See how doctors use Guardant360
to help patients

Guardant360 is comprehensive and accurate

The most validated comprehensive liquid biopsy

Guardant Health has been used over 70,000 times by more than 5,000 oncologists and at all 27 National Comprehensive Network Cancer Centers. Our clinical research collaborations have resulted in over 70 peer-reviewed publications.

Browse our publications >

The vast majority of NCI comprehensive cancer centers use our test, along with a growing number of research and community oncologists.

Learn more about how Guardant360 can help you >